Mayne Pharma Group (MAYNF) News Today $3.00 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Mayne Pharma Hosts Investor Webinar on US Business SegmentsOctober 30 at 9:46 AM | markets.businessinsider.comMayne Pharma to Highlight Growth in US Health SectorsOctober 23, 2024 | markets.businessinsider.comMayne Pharma Group (MAYNF) Receives a Buy from Canaccord GenuitySeptember 23, 2024 | markets.businessinsider.comAustralia's Mayne Pharma sues Sun Pharma over patent infringementJuly 25, 2024 | msn.comMayne Pharma Group LtdJuly 25, 2024 | reuters.comSun Pharma share price hits 52-week high, despite getting sued by Australia's Mayne Pharma, over patent infringementJuly 25, 2024 | msn.comMayne Pharma Group Limited's (ASX:MYX) largest shareholders are individual investors with 38% ownership, institutions own 33%May 12, 2024 | finance.yahoo.comMayne Pharma Group LimitedApril 23, 2024 | afr.comMayne Pharma Group Limited (MAYNF) Q2 2024 Earnings Call TranscriptFebruary 28, 2024 | seekingalpha.comMayne Pharma Group Limited (MAYNF)February 28, 2024 | finance.yahoo.comMayne Pharma Group reports 1H resultsFebruary 27, 2024 | msn.comMayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 29, 2023 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Replimune Group (REPL), Mayne Pharma Group (OtherMAYNF) and Biogen (BIIB)December 6, 2023 | markets.businessinsider.comWhile institutions invested in Mayne Pharma Group Limited (ASX:MYX) benefited from last week's 12% gain, retail investors stood to gain the mostNovember 18, 2023 | finance.yahoo.comShawn O’Brien Buys Handful Of Shares In Mayne Pharma GroupOctober 28, 2023 | finance.yahoo.comStrong week for Mayne Pharma Group (ASX:MYX) shareholders doesn't alleviate pain of five-year lossOctober 23, 2023 | finance.yahoo.comMayne Pharma Group Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagSeptember 1, 2023 | finance.yahoo.comWilsons Sticks to Its Buy Rating for Mayne Pharma Group (MAYNF)June 13, 2023 | markets.businessinsider.comInfomedia wrangler Viburnum butts heads with Mayne Pharma’s boardMay 16, 2023 | afr.comThere's No Escaping Mayne Pharma Group Limited's (ASX:MYX) Muted RevenuesApril 18, 2023 | finance.yahoo.comMayne Pharma Group Limited (ASX:MYX) Shares Could Be 49% Below Their Intrinsic Value EstimateMarch 1, 2023 | finance.yahoo.comDr. Reddy's Seeks Gaining Foothold In Women's Health Via Mayne Pharma's U.S. Generic Prescription DealFebruary 27, 2023 | finance.yahoo.comDr Reddy's Laboratories announces agreement to acquire Mayne Pharma’s U.S. generic prescription product portfolioFebruary 27, 2023 | msn.comDr. Reddy’s Laboratories to acquire Mayne Pharma’s U.S. generic prescription product portfolioFebruary 27, 2023 | msn.comMAYND Mayne Pharma Group LimitedJanuary 31, 2023 | seekingalpha.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Lantheus (LNTH) and Mayne Pharma Group Limited (OtherMAYNF)December 7, 2022 | markets.businessinsider.comTherapeuticsMD enters agreements to license products to Mayne PharmaDecember 5, 2022 | seekingalpha.comMayne Pharma Group Limited (ASX:MYX) Analysts Just Trimmed Their Revenue Forecasts By 19%December 2, 2022 | finance.yahoo.comMayne Pharma Group (ASX:MYX) investors are sitting on a loss of 54% if they invested five years agoNovember 9, 2022 | finance.yahoo.comIs the Mayne Pharma Group Ltd share price in the buy zone after today’s news?September 13, 2022 | fool.com.auAnalysts Are More Bearish On Mayne Pharma Group Limited (ASX:MYX) Than They Used To BeAugust 31, 2022 | finance.yahoo.comDoes This Valuation Of Mayne Pharma Group Limited (ASX:MYX) Imply Investors Are Overpaying?August 16, 2022 | finance.yahoo.comCatalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: ReportAugust 10, 2022 | finance.yahoo.comMAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS® AND EXPAND ACCESS TO BIRTH CONTROLJuly 29, 2022 | finance.yahoo.comMayne Pharma Group Limited (ASX:MYX) insider upped their holding by 120% earlier this yearMay 1, 2022 | finance.yahoo.comCould The Mayne Pharma Group Limited (ASX:MYX) Ownership Structure Tell Us Something Useful?February 8, 2022 | finance.yahoo.comMayne Pharma Group (ASX:MYX) investors are sitting on a loss of 82% if they invested five years agoDecember 5, 2021 | finance.yahoo.comMayne Pharma Group Limited's (ASX:MYX) Path To ProfitabilityOctober 19, 2021 | finance.yahoo.comFDA Approves LEXETTE (R) for Adolescent Plaque PsoriasisSeptember 21, 2021 | finance.yahoo.comMayne Pharma (ASX:MYX) share price drops on class actionAugust 2, 2021 | msn.comMayne Pharma hit with investor class actionAugust 2, 2021 | afr.com Get Mayne Pharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MAYNF and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here MAYNF Media Mentions By Week MAYNF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MAYNF News Sentiment▼0.000.43▲Average Medical News Sentiment MAYNF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MAYNF Articles This Week▼10▲MAYNF Articles Average Week Get Mayne Pharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MAYNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Daiichi Sankyo News Today JCR Pharmaceuticals News Today Kyowa Kirin News Today Ono Pharmaceutical News Today Otsuka News Today Roche News Today Sanofi News Today Virbac News Today Chugai Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MAYNF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mayne Pharma Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mayne Pharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
